A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 159
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : RBA
Long Form : relative binding affinity
No. Year Title Co-occurring Abbreviation
2019 Predicting estrogen receptor binding of chemicals using a suite of in silico methods - Complementary approaches of (Q)SAR, molecular docking and molecular dynamics. ER
2018 Development of QSAR models for predicting the binding affinity of endocrine disrupting chemicals to eight fish estrogen receptor. ER, QSAR
2017 BODIPY-17alpha-ethynylestradiol conjugates: Synthesis, fluorescence properties and receptor binding affinities. ER, PET
2017 Design and synthesis of iodocarborane-containing ligands with high affinity and selectivity toward ERbeta. ---
2017 Development of predictive models for predicting binding affinity of endocrine disrupting chemicals to fish sex hormone-binding globulin. EDCs, hSHBG, QSAR
2017 Oral contraceptives cause evolutionarily novel increases in hormone exposure: A risk factor for breast cancer. EE, OC
2017 Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands. ER, SAR
2015 18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET). AR, DHT, PET
2015 Sequence to structure approach of estrogen receptor alpha and ligand interactions. DES, ERs, SERMs
10  2015 Synthesis and biological evaluation of novel m-carborane-containing estrogen receptor partial agonists as SERM candidates. SERM
11  2014 Measuring the kinetics of the binding of xenoestrogens and estrogen receptor alpha by fluorescence polarization. BPA, ER
12  2012 Identification of HBsAg-specific antibodies from a mammalian cell displayed full-length human antibody library of healthy immunized donor. FACS, Flp-In, FSB, FSE, HBIG, HBsAg, HBV
13  2012 Synthesis and evaluation of 11beta-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists. ER
14  2011 Synthesis and investigations on the oxidative degradation of C3/C5-alkyl-1,2,4-triarylpyrroles as ligands for the estrogen receptor. ER
15  2010 Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications. ERs
16  2009 A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor. ER
17  2008 Biological activity of novel progesterone derivatives having a bulky ester side chains at C-3. AR, Mib
18  2008 Decision trees versus support vector machine for classification of androgen receptor ligands. ---
19  2008 Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies. FFNP, PRs
20  2008 Fluorous tolerance of the estrogen receptor alpha as probed by 11-polyfluoroalkylestradiol derivatives. ERalpha
21  2008 Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate. AlPcS, GRPR, PDT
22  2007 Amide derivatives of 2,3-diarylacrylophenone as estrogen receptor binding ligands. ER
23  2007 An atom counting strategy towards analyzing the biological activity of sex hormones. QSAR
24  2007 Combination of receptor-binding assays and designed mutant receptors for discerning agonists and antagonists. ---
25  2007 CoMSIA and docking study of rhenium based estrogen receptor ligand analogs. CoMSIA, ERalpha, LBD, PV
26  2007 Determining the transrepression activity of xenoestrogen on nuclear factor-kappa B in Cos-1 cells by estrogen receptor-alpha. CMV, CMV-MIEP, hERalpha, MXC, NF-kappaB
27  2007 Synthesis of 3-phenyl-4-phenylvinyl benzopyranones and the corresponding 2,2-dimethyl-benzopyrans with structural similarity to estradiol, as estrogen receptor ligands. ER
28  2006 Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. ERs
29  2006 Derivatives of Z-bisdehydrodoisynolic acid provide a new description of the binding-activity paradox and selective estrogen receptor modulator activity. ERs
30  2006 Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. GR, ICS, PR
31  2006 High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity. ---
32  2006 Metabolism of mometasone furoate and biological activity of the metabolites. MF
33  2006 Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reaction. ER, SERMs
34  2005 Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method. BisA, BISF, CLO, DES, EST, ESTA, FMO, GEN, RAL, TAM
35  2005 Binding of flavonoids from Sophora flavescens to the rat uterine estrogen receptor. ER
36  2005 Comparison of relative binding affinities of endocrine active compounds to fathead minnow and rainbow trout estrogen receptors. DES, fhmER, GEN, MT, MXC, p-NP, p-t-OP, rbtER, TAM
37  2005 Semiempirical QSAR study and ligand receptor interaction of estrogens. ---
38  2005 Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes. ---
39  2004 A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor. AR, CoMFA, QSAR, SARMs
40  2004 Binding of xenoestrogens to the sex steroid-binding protein in plasma from Arctic charr (Salvelinus alpinus L.). acSBP, DIN, OP, SBP
41  2004 Electrophilicity index as a possible descriptor of biological activity. ---
42  2004 Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour. OH-Tam, SERMs
43  2004 Synthesis and binding affinity to human alpha and beta estrogen receptors of various 7-hydroxycoumarins substituted at 4- and 3,4- positions. ERs
44  2004 Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands. CoMFA, GB/SA, LBD, NB
45  2004 Use of trout liver slices to enhance mechanistic interpretation of estrogen receptor binding for cost-effective prioritization of chemicals within large inventories. rtER, VTG
46  2003 CoMFA and docking study of novel estrogen receptor subtype selective ligands. CoMFA, LBD
47  2003 Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor. AR, CoMFA, EDCs
48  2003 Evaluation of 17alpha-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands. ---
49  2003 In vivo and in vitro estrogen bioactivities of alkyl parabens. BuPben, EtPben, IM, IW, MePben, PrPben, sc
50  2003 Spectroscopic QSAR methods and self-organizing molecular field analysis for relating molecular structure and estrogenic activity. CoSA, EEVA, EVA, QSAR, SOMFA
51  2003 Synthesis of novel arylpyrazolo corticosteroids as potential ligands for imaging brain glucocorticoid receptors. GR, PET
52  2003 Synthesis of the 7alpha-cyano-(17alpha,20E/Z)-[125I]iodovinyl-19-nortestosterones: potential radioligands for androgen and progesterone receptors. AR, DHT, IVNT
53  2003 Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines. ERalpha, ERbeta, SERMs
54  2003 Synthesis, receptor binding, molecular modeling, and proliferative assays of a series of 17alpha-arylestradiols. ER, TMEDA
55  2003 [Synthesis and binding affinity of 3-aryl-7-hydroxycoumarins to human alpha and beta estrogen receptors]. ---
56  2002 A reactivity pattern for discrimination of ER agonism and antagonism based on 3-D molecular attributes. ER
57  2002 An integrated "4-phase" approach for setting endocrine disruption screening priorities--phase I and II predictions of estrogen receptor binding affinity. EDCs, EPA, ER
58  2002 Antitumoral activity of a new series of 5,6-dihydrobenzo(a)carbazoles. DHBC, ER, NMU, TAM
59  2002 Improvement of a sensitive enzyme-linked immunosorbent assay for screening estrogen receptor binding activity. BPA, DES, EDCs, ELISA
60  2002 Novel estradiol derivatives labeled with Ru, W, and Co complexes. Influence on hormone-receptor affinity of several organometallic groups at the 17 alpha position. ---
61  2002 Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. ER
62  2001 ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. ER, PR
63  2001 Homology modeling of the estrogen receptor subtype beta (ER-beta) and calculation of ligand binding affinities. ER-alpha, ER-beta
64  2001 Investigations of new lead structures for the design of selective estrogen receptor modulators. DES, ER
65  2001 Use of 13C NMR spectrometric data to produce a predictive model of estrogen receptor binding activity. LOO, SDAR
66  2000 (13)C NMR and electron ionization mass spectrometric data-activity relationship model of estrogen receptor binding. EI MS, LOO, NMR, SDAR
67  2000 A computationally based identification algorithm for estrogen receptor ligands: part 2. Evaluation of a hERalpha binding affinity model. ERs, hERalpha, SAR
68  2000 The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. ER
69  2000 [Competitive binding of some alkyl p-hydroxybenzoates to human estrogen receptor alpha and beta]. ERalpha, PHBA-Et
70  1998 1-Benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assays. ---
71  1998 Application of an androgen receptor assay for the characterisation of the androgenic or antiandrogenic activity of various phenylurea herbicides and their derivatives. 3,4-DCA, 3,4-DCAc
72  1998 Binding of apoB-containing lipoproteins from unfractionated human blood sera to immobilized LDL receptor. ---
73  1998 Human progesterone receptor A and B isoforms in CHO cells. I. Stable transfection of receptor and receptor-responsive reporter genes: transcription modulation by (anti)progestagens. MPA, NE, PROG
74  1998 Human progesterone receptor A and B isoforms in CHO cells. II. Comparison of binding, transactivation and ED50 values of several synthetic (anti)progestagens in vitro in CHO and MCF-7 cells and in vivo in rabbits and rats. CHO, Luc, MMTV, RAA, RANTA
75  1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. cDNA, DDT, ER
76  1998 Synthesis and binding affinities of new 17 alpha-substituted estradiol-rhenium "n + 1" mixed-ligand and thioether-carbonyl complexes. ER
77  1997 QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. CoMFA, QSAR
78  1997 Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species. CoMFA, ER, QSAR, QSARs
79  1997 Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. ppb, RBA-SMA
80  1997 The ovarian progestogen receptor in the spotted seatrout, Cynoscion nebulosus, demonstrates steroid specificity different from progesterone receptors in other vertebrates. 17alpha,20beta-P
81  1996 RU 3117 a steroidal compound with high affinity for sigma sites in rat testis membranes. ---
82  1996 The stereoisomers of 17alpha-[123I]iodovinyloestradiol and its 11beta-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats. DES
83  1996 [Kinetics of interaction of [3H]16alpha,17alpha-cyclohexanoprogesterone with progesterone receptor in the rabbit uterus]. ---
84  1995 6 alpha-[18F]fluoroprogesterone: synthesis via halofluorination-oxidation, receptor binding and tissue distribution. PgR
85  1995 Binding of 17-alpha-methyltestosterone in vitro to human sex hormone binding globulin and rat ventral prostate androgen receptors. DHT, MeT, SHBG
86  1995 Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor. hPR, LNG, LNG-oxime, NORG, PR, rPR
87  1995 Investigation of the configurational and conformational influences on the hormonal activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes. 1. Synthesis, estradiol receptor affinity, and estrogenic activity of diastereomeric [N-alkyl- and N,N'-dialkyl-1,2- bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes. ---
88  1995 Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution. AR
89  1994 Interaction of newly synthesized antiprogesterone ZK98299 with progesterone receptor from human myometrium. PR
90  1993 Progestin 16 alpha, 17 alpha-dioxolane ketals as molecular probes for the progesterone receptor: synthesis, binding affinity, and photochemical evaluation. PgR
91  1993 Species specificity of triphenylethylene derivatives and of compounds with a steroidal backbone for human and rat liver antioestrogen binding site (AEBS). AEBS, TPE
92  1993 The affinity of procymidone to androgen receptor in rats and mice. DHT, LH
93  1993 [Pharmacologic study of the glucocorticoid activity of flunisolide compared with other steroids in the rat]. BDP, BMP, FLU
94  1992 11 beta-amidoalkyl estradiols, a new series of pure antiestrogens. ER, TAM
95  1992 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity. ---
96  1992 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity. ---
97  1992 Antiprogestin ZK-98.299 and progesterone display differential binding characteristics in the human myometrial cytosol. IA, NEM
98  1992 Comparison between the interaction of steroids with [35S]TBPS binding to cerebral cortical and to pituitary membranes: correlation with inhibition of prolactin release. 5 alpha 3 alpha P
99  1992 Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity. ---
100  1992 Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of receptor. ER, THC